Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-014918
Filing Date
2025-05-07
Accepted
2025-05-07 08:03:14
Documents
92
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q clnn20250331_10q.htm   iXBRL 10-Q 1783937
2 EXHIBIT 31.1 ex_762995.htm EX-31.1 12743
3 EXHIBIT 31.2 ex_762996.htm EX-31.2 12508
4 EXHIBIT 32.1 ex_762997.htm EX-32.1 6091
5 EXHIBIT 32.2 ex_762998.htm EX-32.2 6024
11 pipelinemay25_22pct.jpg GRAPHIC 110124
  Complete submission text file 0001437749-25-014918.txt   10519921

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250331.xsd EX-101.SCH 96486
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clnn-20250331_cal.xml EX-101.CAL 56407
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250331_def.xml EX-101.DEF 593137
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250331_lab.xml EX-101.LAB 537380
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250331_pre.xml EX-101.PRE 634180
95 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250331_10q_htm.xml XML 1861098
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39834 | Film No.: 25919391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)